Cetera Investment Advisers
PFE icon

Cetera Investment Advisers’s Pfizer PFE Stock Holding History

Cetera Investment Advisers’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,200
Closed -$12 – 4923
2025
Q4 		$12 Buy
+1,200
New +$30.3K ﹤0.01% 4681

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cetera Investment Advisers's PFE Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Pfizer (PFE) stake by 0.93% in Q2 2026, selling an estimated $783K and leaving 3,183,708 shares worth $76.7M. The position accounts for 0.07% of the portfolio, ranked #282.

Cetera Investment Advisers first reported a position in PFE in Q4 2015 and has held it in 43 quarters since. The position peaked at $90.2M in Q1 2026. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Cetera Investment Advisers held 3,183,708 shares of Pfizer worth $76.7M as of Q2 2026.
  • Cetera Investment Advisers sold 29,919 Pfizer shares in Q2 2026, an estimated $783K.
  • Pfizer made up 0.07% of Cetera Investment Advisers's portfolio in Q2 2026, its #282 holding.
  • Cetera Investment Advisers first reported a position in Pfizer in Q4 2015 and has held it in 43 quarters since.
  • Cetera Investment Advisers's Pfizer position peaked at $90.2M in Q1 2026.
  • 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.